id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ihlr-2009	Sharkey, Catherine M.	Vaccines and Drugs: A Brave New Tort World	2011	8	.pdf	application/pdf	2239	83	46	Professor Davis urges more emphatically that tort litigation is needed for vaccine injuries as a “longstanding com- plement to more formal regulatory action for responding to uncertainty in risk information. In 2011, the U.S. Supreme Court ruled in Bruesewitz v. Wyeth that design defect claims against vaccine manufacturers were preempted.2 This follows closely on the heels of the Court’s decision in Wyeth v. Levine, finding that failure to warn claims against a drug manufacturer were not preempted.3 The symposium contributors—who include two prominent tort and product liability scholars (Mary Davis and Robert Rabin), a policy expert (James Copland), and a seasoned litigator (Malcolm Wheeler)—explore whether it makes sense to have separate legal regimes for vaccines and other pharmaceuticals.	cache/ihlr-2009.pdf	txt/ihlr-2009.txt